actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
enspryng
menarini indria laboratories - indonesia - satralizumab - injeksi - 120 mg
entyvio
takeda indonesia - indonesia - vedolizumab - serbuk infus - 300 mg
entyvio
takeda indonesia - indonesia - vedolizumab - serbuk injeksi - 300 mg/5 ml
human albumin 20% biotest
kimia farma, jakarta - indonesia - humant plasmaprotein - infus - 10 g/ 50 ml
human albumin 20% biotest
kimia farma, jakarta - indonesia - humant plasmaprotein - infus - 10 g/50 ml
human albumin grifols 20%
pharos indonesia - indonesia - human albumin - infus - 0,200 g/l
human albumin grifols 20%
pharos indonesia - indonesia - human albumin - infus - 0,2 g
human albumin grifols 20%
pharos indonesia - indonesia - albumin human - infus - 20 %